T +81 3 6384 3180
David Albagli, PhD is a Local Partner in White & Case's Global Intellectual Property Practice, based in Tokyo. His practice focuses on intellectual property spanning patent litigation, prosecution, opinion work and patent portfolio strategy development as well as pre-litigation counseling and due diligence investigations. Dr. Albagli advises on a wide range of intellectual property matters in the pharmaceutical, chemical, and biotechnology sectors.
Dr. Albagli has extensive experience advising Japanese and foreign clients on securing and enforcing patent rights in the US and coordinating patent strategies across multiple countries and regions.
He has hands-on experience as a patent attorney and scientist in a wide range of fields, particularly in chemistry, nucleic acid technologies, in vitro diagnostics, electrochemistry, microfluidics, polymers, and biochemistry.
He holds a PhD in chemistry and spent two years on a fellowship working at the Research & Development Center of Mitsubishi Chemical Corporation in Yokohama, Japan. He is registered with the US Patent and Trademark Office. He is a frequent lecturer, in English and Japanese, on current topics in US patent law to clients, universities and professional organizations.
Representation of Japanese pharmaceutical company as plaintiff in Abbreviated New Drug Application (ANDA) litigation involving a skin ointment.*
Representation of several Japanese pharmaceutical companies as joint-plaintiffs in ANDA litigation involving an eye medicine.*
Representation of Japanese patent holder in ANDA patent litigation involving an injectable drug used to identify areas of heart damage.*
Representation of Japanese pharmaceutical company in executing contentious process to create freedom-to-operate position.*
Representation of Japanese in vitro diagnostics company in due diligence and patent opinion counseling leading to marketing deal with major US company.*
Representation of Japanese pharmaceutical company in coordinating and conducting freedom-to-operate patent counseling project in five countries.*
Representation of various Japanese chemical and pharma companies in patent prosecution and portfolio management for pharmaceutical, chemical, biotechnology, diagnostic, and microfluidics matters.*
Representation of various Japanese companies in license agreement negotiations and disputes.*
* Experience prior to joining White & Case
"2016 'Invention Day' Memorial Lecture", April 20, 2016: Japan Foods & Biotechnology Intellectual Property Rights Center (JAFBIC),
"Current Trends in US. Patent Practice", February 6, 2015: Japan Foods & Biotechnology Intellectual Property Rights Center (JAFBIC),
"US Patent Seminar- Basic Course", October 30 – December 25, 2014: Toshiba Techno Center,
"Recent US Supreme Court Cases That Change the Way You Practice Patent Law", July 1, 2014: International Association for the Protection of Intellectual Property of Japan (AIPPI Japan),
"Establishing Support for Claims and Claim Amendments with the Specification and Post-Filing Data" and "Trends in Post-Grant Procedures under the AIA", April 15, 2014: First Annual "Invention Day" Conference, JAFBIC,
"The Evolving Legal Landscape for Patent Protection of Stem Cells" , April 13-15, 2013: The 6th Pan Pacific Symposium on Stem Cells and Cancer Research by Taiwan Neurosurgical Society,
Japan Patent Act Amendment: How to Compensate Inventors Now?, Lexology, July 8, 2016, (Co-author)
Prior User Rights in Japan: They Can't Take That Away from Me, Financier Worldwide Global Reference Guide 2012: Intellectual Property, September 2012, (Co-author)
"The Fastest Routes for Green Patents", Managing Intellectual Property, August 2012, (Co-author)
Strategies for Litigating False Marking Cases, Daily Journal, March 30, 2010, (Co-author)
Might No One Have Standing to Bring Suit?, IP Law 360, November 2007, (Co-author)